Remedor Biomed Ltd
Quick facts
Phase 1 pipeline
- A hydrogel containing erythropoietin · Oncology
Stimulates erythropoiesis by binding to and activating the erythropoietin receptor
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: